Affinity Capital Advisors, LLC Renovo Rx, Inc. Transaction History
Affinity Capital Advisors, LLC
- $470 Million
- Q2 2024
A detailed history of Affinity Capital Advisors, LLC transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Affinity Capital Advisors, LLC holds 13,279 shares of RNXT stock, worth $15,005. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,279
Previous 13,279
-0.0%
Holding current value
$15,005
Previous $17,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RNXT
# of Institutions
19Shares Held
1.87MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$1.1 Million0.27% of portfolio
-
Adar1 Capital Management, LLC Austin, TX355KShares$401,4210.08% of portfolio
-
Geode Capital Management, LLC Boston, MA144KShares$162,6280.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$109,7960.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny86.3KShares$97,5370.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $10.2M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...